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Horseradish peroxidase-like type III secretion (TTS1) genes were present in all 116 Northern Australian
Burkholderia pseudomallei isolates tested but were not detected in other common environmental Burkholderia
species. PCR of TTS1 genes may prove valuable as a diagnostic test.
Melioidosis is potentially a life-threatening disease and is
endemic in Northern Australia and Southeast Asia (5). The
etiological agent of melioidosis, Burkholderia pseudomallei, is a
soil- and water-dwelling saprophyte capable of causing cata-
strophic systemic infections in humans and animals (7). Me-
lioidosis is now recognized as the most common cause of fatal
community-acquired bacteremic pneumonia in two hyperen-
demic regions, northeastern Thailand and the Top End of the
Northern Territory of Australia (5).
An intriguing difference in melioidosis epidemiology in
these two regions where melioidosis is hyperendemic is the
lack of correlation between disease incidence and seropositiv-
ity in the respective populations. The average annual incidence
of melioidosis in the Top End is 16.5 out of 100,000 (34.5 out
of 100,000 in the heavy 1998 monsoonal season) with seropos-
itivity ranging between 5 and 13% (5). In comparison, the
annual incidence in Ubon Ratchathani in northeastern Thai-
land is 4.4 out of 100,000, where the majority of the rural
population is seropositive (15). Several explanations may ac-
count for these observations. In Thailand, underreporting of
cases and protective immunity resulting from recurrent expo-
sure may be factors, whereas in the Top End, a higher preva-
lence of risk factors for disease, such as diabetes and alcohol
excess, and/or the presence of more virulent strains may be
important (5). Indeed, different isolates appear to have various
levels of pathogenicity, as demonstrated in animal models and
epidemiological studies. For example, the 50% lethal dose of
42 Australian and Papua New Guinean isolates ranged from 10
CFU to the least virulent of 106 CFU in B. pseudomallei-
susceptible BALB/c mice (17). Furthermore, our studies with
isolates from a goat farm demonstrated that the predominant
B. pseudomallei clone causing disease in the goats was under-
represented in the soil, while the common soil clones were
rarely cultured from goats with melioidosis (unpublished data).
Many different approaches are presently under way to elu-
cidate the mechanisms of B. pseudomallei pathogenesis, and
several factors have been identified to date (10, 12, 18, 21).
Recently, the presence of type III secretion (TTS)-associated
genes in B. pseudomallei was described (1, 19, 20). A variety of
gram-negative pathogens of animals and plants can use TTS
systems to deliver virulence factors to host cells. The range of
diseases caused by these pathogens in different hosts is re-
flected in the myriad of type III-secreted proteins (9). Win-
stanley et al. (19) identified a cluster of genes in B. pseudoma-
llei with high similarity to genes of a horseradish peroxidase
(hypersensitivity response and pathogenicity) locus in Ralsto-
nia solanacearum and developed probes targeting a corre-
sponding region in B. pseudomallei. Furthermore, mining of
the B. pseudomallei genome has been used to identify a second
related TTS gene cluster (11) and a region resembling the
SPI-1 locus of Salmonella enterica serovar Typhimurium, in-
cluding putative homologues of the effectors SipB and SopE
which may be involved in apoptosis, cell fusion, and actin-
associated membrane protrusion (1). PCR and genome se-
quence analyses indicate that, unlike the 50% lethal dose-like
TTS cluster (TTS1), the other two TTS gene clusters are also
present in Burkholderia thailandensis and Burkholderia mallei
(11).
In this study, 116 clinical and environmental B. pseudomallei
isolates collected in the Top End were screened for TTS1
genes. Some of these isolates exhibited relatively low virulence
in mouse models and/or colonized patients without apparent
disease. Environmental isolates were cultured from soil and
water samples collected from various outback communities
and rural and urban properties in the Top End by using Ash-
down’s medium (2). Environmental B. pseudomallei organisms
were identified by using an API 20E (bioMerieux, Marcy
l’Etoile, France), polyclonal antibody-based latex agglutina-
tion, and diagnostic PCR (8). Clinical isolates were identified
by MicroScan Walkaway (Dade Diagnostics, Calif.), and vet-
erinary isolates were identified by GN MicroPlate (Biolog,
Calif.). Genomic DNA was extracted from Burkholderia strains
(3), and TTS1 genes were amplified by using conditions pre-
viously described (20). For the detection of TTS1 genes by
Southern blotting and hybridization, samples of 1 g of
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genomic DNA cut with EcoRI were electrophoresed on a 0.8%
agarose gel (13). The probe was prepared by PCR amplifica-
tion by using the primers described previously (20) and a cos-
mid clone containing the TTS1 genes as a template. The am-
plicon was labeled through five additional PCR cycles with
[-32P]dATP. All methods used were as described previously
(13). L-arabinose assimilation was determined by using GN
MicroPlate, MicroScan Walkaway, or API 20E. Early isolates
for which biochemical profiles were not available were tested
on minimal agar medium supplemented with 0.2% (wt/vol)
L-arabinose as described previously (16).
None of the Top End human, veterinary, and environmental
B. pseudomallei isolates in this study assimilated L-arabinose
(Ara); in fact, no Ara strains (B. thailandensis) have been
detected in Australia to date. PCR amplification of TTS1
genes was performed on 116 Top End B. pseudomallei isolates,
12 B. thailandensis isolates from Thailand, and a further 7
isolates of other Burkholderia species (Table 1 and Fig. 1). All
human, environmental, and veterinary B. pseudomallei isolates
from the Top End were positive for TTS1 genes by PCR. Other
Burkholderia species (B. cepacia, B. spinosa, and B. vietnam-
iensis) commonly encountered by our laboratory in environ-
mental specimens and the B. thailandensis isolates were nega-
tive by this test. These results were confirmed by Southern
hybridization with the TTS1-specific probe (data not shown).
The ability of a strain of B. pseudomallei to cause clinical
illness and the severity of the infection is undoubtedly related
to host factors. In the Top End, 80% of melioidosis cases were
identified as having one or more associated risk factors, includ-
ing excessive alcohol consumption (39%), diabetes (37%),
chronic lung disease (27%), chronic renal disease (10%), and
other risk factors (20%) (4). Furthermore, all but 1 of the 49
fatal cases had at least one identified risk factor (4).
Nevertheless, results from several studies suggest that host
factors are not alone in determining the onset and severity of
melioidosis and that virulence levels vary between strains of B.
pseudomallei. Further variables, including inoculating dose,
time between infection and presentation, and the adequacy of
treatment can influence clinical severity of melioidosis (17).
Our finding that all isolates contained TTS1 genes could not
explain the reported variations in virulence among Top End
isolates in BALB/c mice (17).
An important marker of B. pseudomallei virulence is its
inability to utilize L-arabinose as a sole energy source (Ara).
In contrast, the antigenically cross-reacting Ara B. thailan-
densis strains rarely cause disease (6, 16). Regional mapping of
soils across Thailand demonstrated a correlation between the
Ara/Ara ratio in environmental isolates and incidence of
melioidosis; a ratio of 1.7 in the northeastern hyperendemic
region compared to 0.4 in central Thailand, where melioidosis
cases are uncommon (16). To date, all Top End environmental
B. pseudomallei isolates have proven to be Ara (5), which is
consistent with the higher incidence of melioidosis in this re-
gion. Quantitative counts of environmental B. pseudomallei
have also been correlated with disease incidence (14) and may
play a role in this region.
In conclusion, TTS1 genes appear to be ubiquitous among
Top End clinical and environmental strains of B. pseudomallei.
This is consistent with its environmental existence and its re-
lationship with plant hosts. The TTS1 amplicon was not
present in other environmental Burkholderia species commonly
encountered by our laboratory. Thus, PCR for TTS1 may
prove highly useful for primary identification of B. pseudoma-
llei in environmental samples. We are presently investigating
its general applicability for diagnostic PCR.
We are grateful to Royal Darwin Hospital microbiology staff for
providing clinical isolates, Kevin Fomiatti and the Department of Pri-
mary Industries and Fisheries in Darwin for providing veterinary iso-
lates and undertaking BioLog testing, and V. Wuthiekanun of Mahidol
University, Bangkok, Thailand, for providing B. thailandensis isolates.
We are also thankful to the owners of land at outback communities
FIG. 1. TTS1 PCR results. Lane 1, X174 HinfI; lane 2, B. thai-
landensis; lane 3, Northern Territory human clinical B. pseudomallei;
lane 4, Northern Territory veterinary B. pseudomallei; lane 5, Northern
Territory soil B. pseudomallei; lane 6, Northern Territory water B.
pseudomallei; lane 7, B. cepacia; lane 8, B. spinosa; lane 9, B. vietna-
miensis; lane 10, X174 HinfI.
TABLE 1. TTS1 PCR results
Isolate source
TTS1 PCR test result
No.
negative
No.
positive
Controla 12
Clinical
Human 46
Veterinaryb 28
Environmental
Soil 38
Water 4
Other Burkholderia spp.c
B. cepacia 3
B. spinosa 1
B. vietnamiensis 3
a B. thailandensis (previously L-arabinose-assimilating B. pseudomallei)
(Thailand).
b Veterinary sources: caprine, domestic feline, puma, bovine, ovine, porcine,
canine, alpaca, camel, deer, spider monkey, gibbon, and lorikeet.
c Soil isolates.
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and rural and urban properties in the Top End and in Crocodylus Park,
Darwin, for their interest in our studies and for allowing us to test soil
on their lands.
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ERRATUM
Ubiquity of Putative Type III Secretion Genes among Clinical and
Environmental Burkholderia pseudomallei Isolates in
Northern Australia
H. C. Smith-Vaughan, D. Gal, P. M. Lawrie, C. Winstanley, K. S. Sriprakash,
and B. J. Currie
University of Queensland and Queensland Institute of Medical Research, Brisbane, and Menzies School of Health
Research, Royal Darwin Hospital, Darwin, Australia, and Department of Medical Microbiology and
Genitourinary Medicine, University of Liverpool, Liverpool, United Kingdom
Volume 41, no. 2, p. 883–885, 2003. Page 883, abstract, line 1: “Horseradish peroxidase-like type III secretion genes” should read
“Type III secretion (TTS1) genes of an HRP (hypersensitivity response and pathogenicity)-like locus.”
Page 883, column 2, lines 10 and 11: “a horseradish peroxidase (hypersensitivity response and pathogenicity) locus” should read
“an HRP (hypersensitivity response and pathogenicity) locus.”
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